This company has been acquired
Oak Street Health Crecimiento futuro
Future controles de criterios 3/6
Oak Street Health is forecasted to grow earnings and revenue by 53.6% and 23.4% per annum respectively. EPS is expected to grow by 55.2%. Return on equity is forecast to be 31.9% in 3 years.
Información clave
53.6%
Tasa de crecimiento de los beneficios
55.2%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 17.2% |
| Tasa de crecimiento de los ingresos | 23.4% |
| Rentabilidad financiera futura | 31.9% |
| Cobertura de analistas | Good |
| Última actualización | 02 May 2023 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
CVS close to acquiring Oak Street Health for $10.5B - WSJ
Feb 07Oak Street Health jumps on report of CVS takeover interest
Jan 09Oak Street Health pares gain on report about takeover chances
Nov 16Oak Street Health Q3 2022 Earnings Preview
Nov 07Oak Street Health downgraded at Goldman Sachs citing cloudy outlook
Sep 12Oak Street Health slips aftermarket on secondary stock offering
Aug 16Oak Street Health Q2 2022 Earnings Preview
Aug 01Oak Street Health, Inc. (NYSE:OSH) Shares Could Be 28% Above Their Intrinsic Value Estimate
Jan 28
Oak Street Health Grows Revenue But Struggles With Higher Medical Costs
Dec 22Oak Street Health: Poised For Growth Following RubiconMD Deal
Dec 01Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2025 | 5,215 | -120 | -88 | 117 | 5 |
| 12/31/2024 | 4,117 | -263 | -191 | -84 | 14 |
| 12/31/2023 | 3,053 | -363 | -289 | -227 | 17 |
| 12/31/2022 | 2,161 | -509 | -399 | -309 | N/A |
| 9/30/2022 | 1,977 | -515 | -393 | -285 | N/A |
| 6/30/2022 | 1,820 | -494 | -398 | -295 | N/A |
| 3/31/2022 | 1,650 | -442 | -353 | -260 | N/A |
| 12/31/2021 | 1,430 | -409 | -278 | -197 | N/A |
| 9/30/2021 | 1,285 | -358 | -230 | -181 | N/A |
| 6/30/2021 | 1,114 | -282 | -147 | -116 | N/A |
| 3/31/2021 | 976 | -159 | -94 | -69 | N/A |
| 12/31/2020 | 883 | -120 | -98 | -77 | N/A |
| 9/30/2020 | 808 | -85 | -77 | -57 | N/A |
| 6/30/2020 | 729 | -93 | -103 | -79 | N/A |
| 3/31/2020 | 641 | -145 | -88 | -63 | N/A |
| 12/31/2019 | 557 | -137 | -83 | -55 | N/A |
| 9/30/2019 | 470 | -119 | -65 | -35 | N/A |
| 12/31/2018 | 318 | -119 | -101 | -75 | N/A |
| 12/31/2017 | 185 | -55 | -48 | -35 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: OSH is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: OSH is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: OSH is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: OSH's revenue (23.4% per year) is forecast to grow faster than the US market (7.4% per year).
Ingresos de alto crecimiento: OSH's revenue (23.4% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: OSH's Return on Equity is forecast to be high in 3 years time (31.9%)